Department of Vascular and Interventional Radiology, Jaslok Hospital and Research Centre, Mumbai, India.
Department of Gastroenterology, Jaslok Hospital and Research Centre, Mumbai, India.
J Vasc Interv Radiol. 2021 Dec;32(12):1637-1643. doi: 10.1016/j.jvir.2021.08.023. Epub 2021 Sep 14.
To describe the technical aspects, feasibility, and outcomes in children with Budd-Chiari syndrome (BCS) undergoing transjugular intrahepatic portosystemic shunt (TIPS) creation during infancy.
A retrospective review of infants with BCS undergoing TIPS creation between January 2012 and December 2018 was performed. Eight infants (5 males) underwent TIPS creation (7 for refractory ascites and 1 for refractory variceal bleeding) during the study period. The median age at TIPS creation was 10.5 months (range, 8-16 months). The median elapsed time between presentation and TIPS creation was 6.5 months (range, 0-13 months). The median weight and median pediatric end-stage liver disease score of the infants at the time of TIPS creation were 6.7 kg (range, 5.4-10 kg) and 13 kg (range, 8-18 kg), respectively.
TIPS creation was successful in all patients. There were no immediate postprocedural complications. An 18-gauge hollow needle was manually curved, through which a 21-gauge Chiba needle was inserted to access the portal vein. All patients received 1 or 2 overlapping bare metal stents. One patient was lost to follow-up after the procedure. The median follow-up duration was 32 months (range, 14-51 months). Four of 7 infants needed reintervention. Two children died during the follow-up period. Two children successfully underwent living donor liver transplant, whereas the remaining 3 children were asymptomatic at the follow-up.
TIPS creation was found to be safe and efficacious in improving portal hypertension and growth in these children, although, with a higher rate of reinterventions, possibly due to the use of small, bare metal stents.
描述婴儿期布加综合征(BCS)患者行经颈静脉肝内门体分流术(TIPS)的技术方面、可行性和结果。
对 2012 年 1 月至 2018 年 12 月期间接受 TIPS 治疗的婴儿 BCS 患者进行回顾性分析。在研究期间,有 8 名婴儿(5 名男性)接受了 TIPS 治疗(7 例为难治性腹水,1 例为难治性静脉曲张出血)。TIPS 治疗的中位年龄为 10.5 个月(范围 8-16 个月)。从发病到 TIPS 治疗的中位时间为 6.5 个月(范围 0-13 个月)。TIPS 治疗时婴儿的中位体重和中位儿科终末期肝病评分分别为 6.7kg(范围 5.4-10kg)和 13kg(范围 8-18kg)。
所有患者 TIPS 治疗均成功。无即刻术后并发症。手动弯曲 18G 空心针,通过该针插入 21G Chiba 针以进入门静脉。所有患者均接受 1 或 2 个重叠的裸金属支架。1 例患者在术后失访。中位随访时间为 32 个月(范围 14-51 个月)。7 例中有 4 例需要再次干预。2 例患儿在随访期间死亡。2 例患儿成功接受活体供肝移植,而其余 3 例患儿在随访时无症状。
尽管再次干预率较高,可能是由于使用了小尺寸的裸金属支架,但 TIPS 治疗发现可安全有效地改善这些儿童的门静脉高压和生长情况。